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Letter to the editor
Fractions of plasma gamma-glutamyltransferase in healthy
individuals: Reference values
Dear Editor,
Gamma-glutamyltransferase (GGT) activity, long used as a bio-
marker of liver function and excessive alcohol use [1], has been
recently recognized to be a biomarker of future occurrence of diabetes
and cardiovascular events [2–3], either in unselected populations [4],
or in patients with ascertained ischemic heart disease [5]. Although
the assay is widely used, highly reproducible and sensitive, it holds a
poor speciﬁcity [1].
We recently set up a novel, highly reproducible and sensitive
method for differentiating and quantifying four GGT activity frac-
tions (“big”, “medium”, “small” and “free”: b-, m-, s-, and f-GGT,
respectively) in human blood [6], by means of molecular exclusion
chromatography. We aimed to assess the clinical potential of the
method by establishing reference values in healthy subjects.
Fasting blood samples were obtained between 8:00 and 9:00
from 200 healthy individuals [blood donors, 100 males, mean±SD, age
44±10 years (range, 21–64), 100 females, age 40±11 years (range 20–
64)]. The presence of acute or chronic diseases, and of metabolic
syndrome (according to World Health Organisation criteria [7]) was
excluded by history, clinical examination and comprehensive labora-
tory testing. Subjects on pharmacological treatment for whatever
reasons or with alcohol consumptionN45 g/day for men and N30 g/
day for women were previously excluded from the study. The study
was approved by the Institutional Ethics Committee and all subjects
gave informed consent.
Total and fractional GGT analysis was performed on plasma–EDTA
samples as described previously [9], by using an FPLC system (AKTA
puriﬁer, GE Healthcare) equipped with a gel-ﬁltration column
(Superose 6 HR 10/300 GL, GE Healthcare) and a ﬂuorescence detector
(Jasco FP-2020). GGT activity determination performed on plasma–
EDTA samples showed a correlation coefﬁcient of 0.99 (n=10) with
values obtained either in serum or in plasma–heparin samples. Inter-
assay CV% was 4.65 for total GGT, 6.19 for b-GGT, 5.13 for m-GGT, 4.66
for s-GGT, 4.77 for f-GGT. Fractional GGT area was calculated with the
aid of a computer program (MATLAB Version 7 MathWorks, Inc.) to
resolve overlapping peaks, the curve ﬁtting was conducted with a
nonlinear least-squares minimization algorithm using four exponen-
tially modiﬁed Gaussian (EMG) curves; upper and lower bounds for
the curve amplitude, width, position and asymmetry were set for each
peak.
Our original procedure allowed the analysis of four GGT fractions
in all plasma samples examined, overcoming the low sensitivity of
previously proposed methods, which cannot give homogeneous nor
reproducible results [8–10]. All four GGT fractions showed signiﬁ-
cantly higher values in males than in females (Table 1). In both
genders total plasma GGT, as well as b-, m- and s-GGT fractions,
showed a right-skewed distribution, while f-GGT showed a normal
distribution (PN0.10, Kolmogorov–Smirnov test with Dallal–Wilkin-
son–Lillie for P value).
Plasma GGT fraction analysis might help to specify the complex
interaction between GGT activity and cardiovascular risk factors. We
have found in healthy subjects of both genders that f-GGT fraction,
with a molecular weight of 70 kDa, is the prominent one for total GGT
values in the low-normal range (belowmedian;males:b25U/l, females:
b14 U/l) (Fig. 1). For total GGT levels above median values, known to be
associated with cardiovascular risk factors such as BMI, DAP, serum
triglycerides and LDL cholesterol [4], we observed a consistent
logarithmic increase in b-, m- and s-GGT fractions (Fig. 1), whose
molecular weights are respectively in the range of VLDL, LDL and HDL
[9]. Nevertheless, the relationship between fractional GGT, lipoproteins
and cardiovascular disorders needs further characterization.
In conclusion, GGT fraction analysis by high performance mole-
cular exclusion chromatography could improve the low speciﬁcity of
current GGT assay, allowing the discrimination of underlying risk and/
or pathologic conditions.
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Table 1
Total and fractional plasma GGT activities in healthy humans
Males (n=100) Females (n=100)
Median 5th–95th percentile Median 5th–95th percentile P
Total GGT⁎ 25.3 12.3–60.5 14.4 8.4–30.9 b0.001
b-GGT⁎ 2.4 0.7–10.7 1.1 0.4–5.2 b0.0001
m-GGT⁎ 1.0 0.2–3.3 0.5 0.2–1.2 b0.0001
s-GGT⁎ 9.2 2.8–33.7 3.9 1.5–11.6 b0.0001
f-GGT 13.2 8.3–19.6 8.9 5.9–12.5 b0.0001
Data are expressed as U/l. ⁎Student's t-test performed on ln transformed data. N.S: not
signiﬁcant.
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Fig. 1. Elution proﬁle of fractional GGTactivity corresponding to the 25th (dashed line), 50th (solid line) and 75th (dotted line) percentile of total GGT in healthy males (A, n=100) and
healthy females (B, n=100). Fractional GGT analysis was performed on plasma–EDTA samples by high performance gel-ﬁltration chromatography, GGT activity was speciﬁcally
detected by an on-line post-column reaction with a ﬂuorescent substrate, γGluAMC [6].
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